Galecto (GLTO) announced the appointment of Sherwin Sattarzadeh, former Chief Business Officer of Blueprint Medicines Corporation, as Chief Operating Officer, COO, and Dr. Becker Hewes, former Chief Medical Officer of Blueprint Medicines, as Chief Medical Officer, CMO, effective January 5, 2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLTO: